The Russian Federal Biomedical Agency introduced a cure for coronavirus infection. It is mefloquine-based medication, the press service of the agency reports.
It is specified that the Pharmzashchita Research and Production Center has developed a treatment regimen taking into account Chinese and French experience.
"The medication with high selectivity blocks the cytopathic effect of coronavirus in cell culture and inhibits its replication, and the immunosuppressive effect of mefloquine prevents the activation of the inflammatory response caused by the virus. Adding macrolide antibiotics and synthetic penicillins not only prevents the formation of a secondary bacterial-viral syndrome but also increases the concentration of the antiviral agent in blood plasma and lungs, " the head of the Russian Federal Biomedical Agency, Veronika Skvortsova said.
According to her, this will provide effective treatment for patients with COVID-19 of varying severity.
The press service added that the mefloquine-based effective and safe coronavirus-preventive scheme is being developed.
It is proposed to include medication in the guidelines of the Ministry of Health, RIA Novosti reports.
